Jinduicheng Molybdenum Co Ltd (601958)
Shanghai Stock Exchange · China · prices in CNY · close of 27 Oct 2026
Key indicators
| Last close | CNY 16.76 |
|---|---|
| 52-week range | 13.50 – 31.61 |
| Return, 1 month / 3 months | −14.9% / −20.8% |
| Return, 1 year / 3 years | +12.6% / +67.1% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 59.0% |
| Worst drawdown (1 year) | -45.0% |
| Average daily value traded | 790.28M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Jinduicheng Molybdenum Company is a Chinese mining and processing company based in Shaanxi province. It extracts molybdenum ore and turns it into products such as molybdenum concentrate, molybdenum oxide and molybdenum metal, which are used in steelmaking, alloys and industrial applications. Its customers are mainly industrial and metals-processing businesses that need molybdenum as an input for their own manufacturing. The company operates mines and processing facilities in China and supplies both domestic and international markets.
The shares are listed on the Shanghai Stock Exchange in China under the code 601958, and the price on this page is in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Jinduicheng Molybdenum Co Ltd (601958) trades on the Shanghai Stock Exchange in China. It last closed at CNY 16.76 on 27 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,022 of 2,280 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.6% and over the last three months it fell 20.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 46 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -21.0% | ||
| From 52-week high | -45.0% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -20.8% | ||
| 6-month return | -12.6% | ||
| 12-month return, skipping the last month | 32.4% | ||
| Stability (higher is calmer) | 35 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 59.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.0% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 790.28M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.3% |
|---|---|
| 1 month | −14.9% |
| 3 months | −20.8% |
| 6 months | −12.6% |
| 1 year | +12.6% |
| 3 years | +67.1% |
| 5 years | +136.7% |
Signals
| 50-day / 200-day average | 20.50 / 21.20 |
|---|---|
| Golden / death cross (60 days) | Death, 5 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2023 | CNY 0.3000 |
| 24 Jun 2022 | CNY 0.1000 |
| 25 Jun 2021 | CNY 0.2500 |
| 3 Jul 2020 | CNY 0.3000 |
| 31 Oct 2019 | CNY 0.0400 |
| 3 Jul 2019 | CNY 0.1000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.